A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF less than 35 percent) and Mild to Moderate Heart Failure

Trial Profile

A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF less than 35 percent) and Mild to Moderate Heart Failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Mar 2010

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Heart failure; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Mar 2010 Results published in Circulation.
    • 01 Sep 2006 Status change
    • 19 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top